---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-008641"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2026-02-17T23:59:59+00:00"
generated_at: "2026-05-16T02:40:13.234023+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q4 revenue falls 37% to $75.1M; net loss $18.1M, guides FY26 rev $270-300M

## Summary
- Revenue $75.1M, down 36.9% YoY; active earning coaches down 40.6% to 16,100.
- Net loss $18.1M ($1.65 EPS) includes $12.1M non-cash tax valuation allowance ($1.10/sh).
- Full year 2025 revenue $385.8M (-36% YoY); net loss $18.7M (-$1.70 EPS).
- Guides Q1 2026 rev $65-80M, loss $0.15-$0.70/sh; FY26 rev $270-300M, loss $1.55-$2.75/sh.

## SEC filing metadata
- accession: 0001628280-26-008641
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2026-02-17T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828026008641/0001628280-26-008641-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828026008641/med-20260217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-008641
- JSON: https://secwatch.observer/filing/0001628280-26-008641.json
- Plain text: https://secwatch.observer/filing/0001628280-26-008641.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.